On October 30, 2026, the Office of Environmental Health Hazard Assessment (OEHHA) of California, the United States, released three Notices of Intent to List, proposing to list perfluorobutanoic acid (PFBA) and its related salts, perfluorohexanoic acid (PFHxA) and its related salts, and perfluorodecanoic acid (PFDA) and its related salts as substances known to cause reproductive toxicity under the Safe Drinking Water and Toxic Enforcement Act of 1986 (i.e., California Proposition 65).
All three substances belong to per- and polyfluoroalkyl substances (PFAS), and all three notices are being advanced through the “Authoritative Bodies” listing mechanism.
Wide Applications of PFAS and Their Detection in Consumer Products
PFAS are widely used in consumer and industrial products due to their heat-resistant, oil-proof, stain-proof, and water-proof properties, but they persist in the environment and can accumulate in the human body, posing a long-term threat.
Among them, PFDA has been detected in consumer products such as cosmetics, outdoor textiles, carpets, ski wax, and leather.
Health Effects
Toxicological assessments by the U.S. Environmental Protection Agency (EPA) show that exposure to PFBA can cause developmental delay; PFHxA mainly causes developmental toxicity, manifested as reduced body weight in offspring; PFDA has the broadest toxic effects, causing developmental toxicity and damaging the male and female reproductive systems.
Relevant studies show that exposure to these substances during pregnancy can lead to adverse outcomes: low birth weight brings long-term health damage, including increased disease risk and shortened life expectancy; delayed eye opening can interfere with the normal development of the visual system. In addition, PFDA harms multiple organ systems, including the liver, immune system, and reproductive system.
Comment Submission and Follow-up Arrangements
The public may submit comments on whether the three substances meet the Authoritative Bodies listing criteria before November 30, 2026; OEHHA recommends submitting comments preferably through its official website.
After the substances are officially listed under California Proposition 65, products containing them and sold in California will be required to bear warning labels; if not compliant, companies may also face litigation risks.
CIRS Reminder
- All three substances are persistent PFAS, and PFDA has been detected in cosmetics. California has previously passed the AB 2771 bill, which prohibits the intentional addition of PFAS in cosmetics sold in California from January 1, 2025. Enterprises exporting cosmetics, textiles, and other consumer products to California should screen their product formulas and raw materials for the presence or inadvertent introduction of these substances, and assess their warning label obligations after formal listing.
- The three Notices of Intent to List are currently in the comment period, and OEHHA will decide whether to formally list the substances after the comment period ends. Relevant enterprises are advised to continuously follow Proposition 65 developments and global PFAS regulatory trends, adjust product formulas and compliance strategies in a timely manner, and reduce compliance and litigation risks.
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
Our Services
- The United States Agent
- The United States FDA Cosmetic Facility Registration
- The United States FDA Cosmetic Product Listing
- The United States FDA OTC Drug Registration
- The United States Color Additive Batch Certification
- The United States Cosmetic/OTC Drug Labeling Review
- International Cosmetic Ingredient Name (INCI) Application
Further Information:

